Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
淋巴瘤中人内源性逆转录病毒、HIV 和 EBV 之间的监管串扰
基本信息
- 批准号:10616708
- 负责人:
- 金额:$ 117.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AIDS related cancerAIDS-Related Diffuse Large B-cell LymphomaAcquired Immunodeficiency SyndromeAffectB-Cell LymphomasB-LymphocytesBCL2 geneBCL6 geneBindingBiologyBrazilCD4 Positive T LymphocytesCell LineCell ProliferationCellsClear cell renal cell carcinomaCoculture TechniquesCommon NeoplasmComplexCytotoxic T-LymphocytesDNADNA Transposable ElementsDataDeveloped CountriesDevelopmentDiseaseElementsEndogenous RetrovirusesEnhancersEnvironmental Risk FactorEpitopesEpstein-Barr Virus InfectionsEvolutionFamilyGene ExpressionGenesGeneticGenomicsGrantHIVHIV InfectionsHIV SeronegativityHumanHuman CloningHuman GenomeHuman Herpesvirus 4Immune TargetingImmunologyImmunophenotypingImmunotherapyIn VitroIncidenceIndividualInfectionJunk DNAK-18 conjugateLinkLymphomaLymphoma cellLymphomagenesisMalignant NeoplasmsMediatingMedicineMolecularMorphologyNucleic AcidsOncogenicPathogenesisPathologicPatientsPatternPersonsPhysiologicalPhysiologyPlayProcessProspective cohortProteinsProto-OncogenesRegulationRepressionRetrospective cohortRetroviridaeRoleSamplingSpecialistStandardizationSystemT-LymphocyteT-Lymphocyte EpitopesTestingTherapeutic InterventionTissuesTonsilTranslatingTumor SubtypeTumor Suppressor GenesUnited StatesUntranslated RNAUp-RegulationViralViral GenomeViremiaVirusWorkcomputerized toolsexomein vitro Modelinfected B celllarge cell Diffuse non-Hodgkin&aposs lymphomalymph nodesneoplastic cellnew therapeutic targetperipheral bloodpromoterresponseribosome profilingsingle-cell RNA sequencingsynergismtargeted treatmenttranscriptome sequencingtranscriptomicstumortumor microenvironmenttumor progressiontumorigenesis
项目摘要
PROJECT SUMMARY/ABSTRACT
Approximately 8% of the human genome is composed of sequences directly derived from germline infections of
diverse retroviruses, which have accumulated over the past ~100 million years of mammalian evolution. None
of these human endogenous retroviruses (HERVs) are known to represent fully functional retroviruses, but most
have retained noncoding regulatory sequences that can control expression of cellular genes acting as promoters
or enhancers, and some still encode proteins with various functional activities. While HERV sequences are often
ignored as merely inconsequential ‘junk’ DNA, there is evidence that a subset of these elements play crucial
roles in human physiology and disease, including cancer. Our previous work, as well as that of others, have
shown that both HIV and EBV infections activate certain HERV families that have oncogenic activities, and our
preliminary data reveal an overlap between these elements. Given that diffuse large B cell lymphomas (DBCL)
are frequently associated with EBV infection in people living with HIV, we hypothesize that there is a complex
intercellular regulatory crosstalk between AIDS related (AR)-DLBCL, HIV-infected T cells and the tissue
microenvironment, that is in part mediated by a specific subset of HERVs and their derived products that are
synergistically activated and promote oncogenesis. We will study DLBCL obtained from patients with or without
EBV (and with or without HIV) from the USA and Brazil, which will be comprehensively characterized
pathologically and molecularly using single-cell genomics and spatial transcriptomics. We will analyze these data
using computational tools we have tailored to profile and link HERV and gene expression. Furthermore, we will
establish in vitro models to dissect with precision the functional impact of HERV on the crosstalk between T cells
infected by HIV and B cells with or without EBV. We will also determine if differential HERV expression creates
neoantigenic epitopes, a feature that can be exploited for immunotherapy. This will be accomplished through
three specific aims: 1) Characterize and profile HERV regulation and expression within single cells in DLBCL
and AR-DLBCL; 2) Establish in vitro models to dissect the interaction between cellular and endogenous and
exogenous viruses in AR-DLBCL; 3) Identification of neo-antigenic HERV epitopes in DLBCL and ascertain if
cloned HERV specific CTL can lyse lymphoma cells in vitro. Our team consists of specialists in lymphoma biology
and medicine, transposable elements and HERVs, HIV and EBV viral immunology. Together, we will generate
understandings of how HERVs contribute to the pathogenesis of AR-DLCBL, and identify new antigenic targets
for novel therapies.
项目概要/摘要
大约 8% 的人类基因组由直接源自生殖系感染的序列组成
不同的逆转录病毒,在过去约 1 亿年的哺乳动物进化中积累。
已知这些人类内源性逆转录病毒 (HERV) 代表了功能齐全的逆转录病毒,但大多数
保留了非编码调控序列,可以作为启动子控制细胞基因的表达
或增强子,有些仍然编码具有各种功能活性的蛋白质,而 HERV 序列通常是编码的。
尽管被认为只是无关紧要的“垃圾”DNA,但有证据表明这些元素的一个子集起着至关重要的作用
我们之前以及其他人的工作在人类生理学和疾病(包括癌症)中发挥了作用。
研究表明,HIV 和 EBV 感染都会激活某些具有致癌活性的 HERV 家族,我们的研究
鉴于弥漫性大 B 细胞淋巴瘤 (DBCL),初步数据显示这些因素之间存在重叠。
经常与 HIV 感染者的 EBV 感染相关,我们认为存在复杂的关系
艾滋病相关 (AR)-DLBCL、HIV 感染的 T 细胞和组织之间的细胞间调节串扰
微环境,部分是由 HERV 的特定子集及其衍生产品介导的
我们将研究从患有或不患有 DLBCL 的患者身上获得的协同激活和促进肿瘤发生。
来自美国和巴西的 EBV(以及带有或不带有 HIV),将对其进行全面表征
我们将使用单细胞基因组学和空间转录组学从病理学和分子学角度分析这些数据。
使用我们定制的计算工具来分析和连接 HERV 和基因表达。
建立体外模型,精确剖析 HERV 对 T 细胞间串扰的功能影响
被 HIV 和 B 细胞感染(有或没有 EBV),我们还将确定差异 HERV 表达是否会产生。
新抗原表位,一种可用于免疫治疗的特征,这将通过它来实现。
三个具体目标:1) 表征和分析 DLBCL 单细胞内 HERV 的调控和表达
和AR-DLBCL;2)建立体外模型来剖析细胞和内源性和
AR-DLBCL 中的外源病毒;3) DLBCL 中新抗原 HERV 表位的鉴定并确定是否
克隆的 HERV 特异性 CTL 可以在体外裂解淋巴瘤细胞。我们的团队由淋巴瘤生物学专家组成。
和医学、转座因子和 HERV、HIV 和 EBV 病毒免疫学一起,我们将产生。
了解 HERV 如何促进 AR-DLCBL 的发病机制,并确定新的抗原靶标
用于新疗法。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ribosomal profiling of human endogenous retroviruses in healthy tissues.
- DOI:10.1186/s12864-023-09909-x
- 发表时间:2024-01-02
- 期刊:
- 影响因子:4.4
- 作者:Dopkins, Nicholas;Singh, Bhavya;Michael, Stephanie;Zhang, Panpan;Marston, Jez L.;Fei, Tongyi;Singh, Manvendra;Feschotte, Cedric;Collins, Nicholas;Bendall, Matthew L.;Nixon, Douglas F.
- 通讯作者:Nixon, Douglas F.
3D chromosomal architecture in germinal center B cells and its alterations in lymphomagenesis.
- DOI:10.1016/j.gde.2022.101915
- 发表时间:2022-06
- 期刊:
- 影响因子:4
- 作者:Papin, Antonin;Cesarman, Ethel;Melnick, Ari
- 通讯作者:Melnick, Ari
Endogenous Reverse Transcriptase Inhibition Attenuates TLR5-Mediated Inflammation.
- DOI:10.1128/mbio.03280-22
- 发表时间:2023-02-28
- 期刊:
- 影响因子:6.4
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ETHEL CESARMAN其他文献
ETHEL CESARMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ETHEL CESARMAN', 18)}}的其他基金
Tri-I Stimulating Access to Research in Residency program (Tri-I StARR - NIAID)
Tri-I 促进住院医师研究项目 (Tri-I StARR - NIAID)
- 批准号:
10592130 - 财政年份:2023
- 资助金额:
$ 117.81万 - 项目类别:
Rapid Sample-to-Answer Diagnosis of Kaposi's Sarcoma Across Sub-Saharan Africa using KS-COMPLETE
使用 KS-COMPLETE 对撒哈拉以南非洲地区的卡波西肉瘤进行快速样本到答案诊断
- 批准号:
10416778 - 财政年份:2022
- 资助金额:
$ 117.81万 - 项目类别:
Rapid Sample-to-Answer Diagnosis of Kaposi's Sarcoma Across Sub-Saharan Africa using KS-COMPLETE
使用 KS-COMPLETE 对撒哈拉以南非洲地区的卡波西肉瘤进行快速样本到答案诊断
- 批准号:
10642906 - 财政年份:2022
- 资助金额:
$ 117.81万 - 项目类别:
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
淋巴瘤中人内源性逆转录病毒、HIV 和 EBV 之间的监管串扰
- 批准号:
10228431 - 财政年份:2021
- 资助金额:
$ 117.81万 - 项目类别:
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
淋巴瘤中人内源性逆转录病毒、HIV 和 EBV 之间的监管串扰
- 批准号:
10398963 - 财政年份:2021
- 资助金额:
$ 117.81万 - 项目类别:
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
(PQ 6) KSHV 肿瘤发生和 KS 免疫环境的新模型
- 批准号:
10737765 - 财政年份:2020
- 资助金额:
$ 117.81万 - 项目类别:
(PQ 6) New Models of KSHV Oncogenesis and KS Immune Environment
(PQ 6) KSHV 肿瘤发生和 KS 免疫环境的新模型
- 批准号:
10397107 - 财政年份:2020
- 资助金额:
$ 117.81万 - 项目类别:
相似海外基金
Exposing synthetic lethal vulnerabilities in EBV-positive AIDS-NHL through novel replication dependency factors
通过新型复制依赖性因子揭示 EBV 阳性 AIDS-NHL 的综合致命脆弱性
- 批准号:
10700376 - 财政年份:2023
- 资助金额:
$ 117.81万 - 项目类别:
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
淋巴瘤中人内源性逆转录病毒、HIV 和 EBV 之间的监管串扰
- 批准号:
10228431 - 财政年份:2021
- 资助金额:
$ 117.81万 - 项目类别:
(PQ4) Role of HIV-induced PLK1 Activation in Regulation of gamma-Herpesvirus Reservoirs in Lymphocytes
(PQ4) HIV 诱导的 PLK1 激活在调节淋巴细胞中 γ-疱疹病毒储库中的作用
- 批准号:
10228415 - 财政年份:2021
- 资助金额:
$ 117.81万 - 项目类别: